Literature DB >> 5800876

Radiosensitization of malignant brain tumours with bromouridine (thymidine analogue).

T Hoshino, K Sano.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5800876     DOI: 10.3109/02841866909134433

Source DB:  PubMed          Journal:  Acta Radiol Ther Phys Biol        ISSN: 0567-8064


× No keyword cloud information.
  9 in total

1.  Modification of malignancy by 5-bromodeoxyuridine. Studies of reversibility and immunological effects.

Authors:  S Silagi
Journal:  In Vitro       Date:  1971 Sep-Oct

2.  In vivo bromodeoxyuridine incorporation in human gastric cancer: a study on formalin-fixed and paraffin-embedded sections.

Authors:  M Danova; A Riccardi; S Brugnatelli; R Fiocca; M Girino; L Villani; P Giordano; P Dionigi; M Giordano; R Buttini
Journal:  Histochem J       Date:  1988-03

3.  Effects of intralesional injection of cisplatin dissolved in urografin and lipiodol on Ehrlich ascites tumor and normal tissues of CD-1 mice.

Authors:  J E Landrito; K Yoshiga; K Sakurai; K Takada
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

Review 4.  The application of 5-bromodeoxyuridine in the management of CNS tumors.

Authors:  A Freese; D O'Rourke; K Judy; M J O'Connor
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

5.  Proliferative activity of meningiomas as evaluated by bromodeoxyuridine uptake examination.

Authors:  M Fukui; T Iwaki; H Sawa; T Inoue; I Takeshita; K Kitamura
Journal:  Acta Neurochir (Wien)       Date:  1986       Impact factor: 2.216

6.  Repair and fixation of potentially lethal damage (PLD) as demonstrated by delayed plating or incubation with araA in contact inhibited refed plateau-phase C3H mouse embryo 10 T1/2 cells grown in the presence of BrdUrd.

Authors:  G Iliakis; E Wright; F Q Ngo
Journal:  Radiat Environ Biophys       Date:  1987       Impact factor: 1.925

7.  Rapid detection of S-phase cells by anti-bromodeoxyuridine monoclonal antibody in 9L brain tumor cells in vitro and in situ.

Authors:  T Nagashima; T Hoshino
Journal:  Acta Neuropathol       Date:  1985       Impact factor: 17.088

8.  Immunocytochemical demonstration of S-phase cells by anti-bromodeoxyuridine monoclonal antibody in human brain tumor tissues.

Authors:  T Nagashima; S J DeArmond; J Murovic; T Hoshino
Journal:  Acta Neuropathol       Date:  1985       Impact factor: 17.088

9.  A correlative study of in vivo and in vitro labeling index using bromodeoxyuridine in human brain tumors.

Authors:  K Kharbanda; A K Dinda; C Sarkar; A K Karak; R Dhir; M Mathur; S Roy
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.